CompletedNCT01076361
Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study
Observational studyMultiple countriesBipolarity
Understand this study
- Listed locations
- Anchorage and 105 more locationsSee all locations and recruitment
Study information
Study start dateSeptember 1999
- Recruitment status
- Completed
- Enrollment listed in the registry
- 370
- Sponsor
- Medtronic
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- United States, Australia, France, ...
- Age range
- Not clearly listed
- Official registry ID
- NCT01076361
- Official title
Show the full official title
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedAnchorage, United States · Gilbert, United States · Scottsdale, United States
100 more locations
- Little Rock, United States
- Bakersville, United States
- Chula Vista, United States
- Downey, United States
- East Palo Alto, United States
- Los Angeles, United States
- Salinas, United States
- Torrance, United States
- Van Nuys, United States
- Colorado Springs, United States
- Denver, United States
- Washington D.C., United States
- Clearwater, United States
- Jacksonville, United States
- Melbourne, United States
- Ocala, United States
- Wellington, United States
- Atlanta, United States
- Columbus, United States
- Marietta, United States
- Oak Lawn, United States
- Indianapolis, United States
- Newburgh, United States
- Des Moines, United States
- Kansas City, United States
- Lexington, United States
- Louisville, United States
- Alexandria, United States
- Baton Rouge, United States
- Salisbury, United States
- Silver Spring, United States
- Towson, United States
- Grand Blanc, United States
- Marquette, United States
- Saginaw, United States
- Southfield, United States
- Robbinsdale, United States
- Rochester, United States
- Saint Paul, United States
- Lebanon, United States
- Browns Mills, United States
- Newark, United States
- Ocean City, United States
- Parlin, United States
- West Orange, United States
- Albuquerque, United States
- Mineola, United States
- Greensboro, United States
- Hickory, United States
- Cincinnati, United States
- Cleveland, United States
- Toledo, United States
- Portland, United States
- Doylestown, United States
- Lancaster, United States
- Sayre, United States
- Columbia, United States
- Florence, United States
- Sioux Falls, United States
- Chattanooga, United States
- Germantown, United States
- Memphis, United States
- Nashville, United States
- Amarillo, United States
- Austin, United States
- Dallas, United States
- Fort Worth, United States
- Houston, United States
- San Antonio, United States
- The Woodlands, United States
- Burlington, United States
- Chesapeake, United States
- Fairfax, United States
- Olympia, United States
- Spokane, United States
- Madison, United States
- Milwaukee, United States
- Bedford Park, Australia
- Linz, Austria
- Vienna, Austria
- Hasselt, Belgium
- Calgary, Canada
- Hamilton, Canada
- Ottawa, Canada
- Toronto, Canada
- Montreal, Canada
- Ste-Foy, Canada
- Regina, Canada
- Copenhagen, Denmark
- Marseille, France
- Homburg/Saar, Germany
- Catanzaro, Italy
- Reggio Emilia, Italy
- Udine, Italy
- Eindhoven, Netherlands
- Rotterdam, Netherlands
- Belgrade, Serbia and Montenegro
- Valencia, Spain
- Skövde, Sweden
- Zurich, Switzerland
Questions about this study
Who is behind this study?
The study sponsor is Medtronic.
